Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Bioheart has secured worldwide non-exclusive distribution rights to the Bioheart 3370 heart failure monitor, an interactive and simple-to-use at-home intelligent device designed specifically to improve available healthcare to patients outside hospitals who are suffering from heart failure.
Subscribe to our email newsletter
The Bioheart 3370 heart failure monitor collects data from a range of vital sign monitoring devices, a weight scale and a voice-activated heart failure status questionnaire, and provides for secure data transmission to an HTTP server on the Internet.
The monitor is designed with unique features that make the device state-of-the-art for system integrators working the area of home monitoring, e-health and remote disease management. Regular data input and monitoring enables the health care team to detect signs and symptoms of change as they occur.
The device, manufactured by RTX Healthcare, has 510k market clearance from the FDA for marketing in the US and CE mark approval for marketing in Europe and other countries that follow this mark.
The company is planning to begin immediate commercial distribution. The Bioheart 3370 at-home heart failure monitor will be available through physician prescription.